Skip to content

SCS for the Treatment Of Chronic Pain of the Upper Extremities

CompletedNot applicableNCT02703818
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This is a prospective, multi-center post-market study of the Senza System in subjects with chronic, intractable pain of the upper extremities. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.

Study details

Official title
Multi-Center, Prospective, Clinical Trial of the Senza™ Spinal Cord Stimulation (SCS) System in the Treatment Of Chronic Pain of the Upper Extremities
Conditions
  • Upper Extremity Pain
Interventions
  • Device: Senza
Sponsor
Nevro Corp
Start date
2016-02
Primary completion
2017-08
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: 1. Have been diagnosed with chronic, intractable pain of an upper extremity of neuropathic origin, which has been refractory to conservative therapy for a minimum of 3 months. 2. Have an average pain intensity (over a period of 7 days) of an upper extremity of ≥ 5 out of 10 cm on the Visual Analog Scale (VAS) at enrollment. 3. Be on stable pain medications for at least 28 days and be willing to stay on those medications with no dose adjustments until activation of the permanently implanted SCS device. 4. Be 18 years of age or older at the time of enrollment. 5. Be an appropriate candidate for the surgical procedures required in this study. 6. Be capable of subjective evaluation, able to read and understand English-written questionnaires, and are able to read, understand and sign the written inform consent in English. 7. Have stable neurological status measured by motor, sensory and reflex function. Key Exclusion Criteria: 1. Have a medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures. 2. Have a current diagnosis of a progressive neurological disease. 3. Have a current diagnosis or condition such as a coagulation disorder, bleeding diathesis, platelet dysfunction, progressive peripheral vascular disease or uncontrolled diabetes mellitus that presents excess risk for performing the procedure. 4. Have mechanical spine instability as determined. 5. Have significant stenosis, based on MRI. 6. Have an existing drug pump and/or another active implantable device (switched on or off) such as a pacemaker or other SCS devices. 7. Have a condition currently requiring or likely to require the use of whole body MRI or diathermy. 8. Be pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile or be at least 2 years post-menopausal). 9. Have within 6 months of enrollment a significant untreated addiction to dependency producing medications, alcohol or illicit drugs. 10. Be involved in an injury claim under current litigation. 11. Have a pending or approved worker's compensation claim. 12. Have evidence of an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention and/or ability to evaluate treatment outcome, as determined by a psychologist.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02703818